@article{4eab6363a6b647c6b6c2fc270b161671,
title = "Exposure to food allergens through inflamed skin promotes intestinal food allergy through the thymic stromal lymphopoietin-basophil axis",
abstract = "Background Exposure to food allergens through a disrupted skin barrier has been recognized as a potential factor in the increasing prevalence of food allergy. Objective We sought to test the immunologic mechanisms by which epicutaneous sensitization to food allergens predisposes to intestinal food allergy. Methods Mice were epicutaneously sensitized with ovalbumin or peanut on an atopic dermatitis-like skin lesion, followed by intragastric antigen challenge. Antigen-specific serum IgE levels and TH2 cytokine responses were measured by ELISA. Expression of type 2 cytokines and mast cell proteases in the intestine were measured by using real-time PCR. Accumulation of basophils in the skin and mast cells in the intestine was examined by using flow cytometry. In vivo basophil depletion was achieved by using diphtheria toxin treatment of Baso-DTR mice. For cell-transfer studies, the basophil population was expanded in vivo by means of hydrodynamic tail vein injection of thymic stromal lymphopoietin (TSLP) cDNA plasmid. Results Sensitization to food allergens through an atopic dermatitis-like skin lesion is associated with an expansion of TSLP-elicited basophils in the skin that promote antigen-specific TH2 cytokine responses, increased antigen-specific serum IgE levels, and accumulation of mast cells in the intestine, promoting the development of intestinal food allergy. Critically, disruption of TSLP responses or depletion of basophils reduced the susceptibility to intestinal food allergy, whereas transfer of TSLP-elicited basophils into intact skin promoted disease. Conclusion Epicutaneous sensitization on a disrupted skin barrier is associated with accumulation of TSLP-elicited basophils, which are necessary and sufficient to promote antigen-induced intestinal food allergy.",
keywords = "Food allergy, IgE, atopic dermatitis, basophils, epicutaneous sensitization, mast cells, thymic stromal lymphopoietin",
author = "Mario Noti and Kim, {Brian S.} and Siracusa, {Mark C.} and Rak, {Gregory D.} and Masato Kubo and Moghaddam, {Amin E.} and Sattentau, {Quentin A.} and Comeau, {Michael R.} and Spergel, {Jonathan M.} and David Artis",
note = "Funding Information: Research in the Artis laboratory is supported by the National Institutes of Health ( AI061570, AI087990, AI074878, AI106679, AI095466, AI095608, AI102942, and AI097333 to D.A.); the Crohn{\textquoteright}s and Colitis Foundation of America (to D.A.) ; the Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award (to D.A.) ; the Swiss National Science Foundation Prospective and Advanced Research Fellowships (PBBEP3_130438 and PA00P3_136468 to M.N.); T32-AR007465 and KL2-RR024132 to B.S.K.; and F32-AI085828 to M.C.S. The ACC Flow Cytometry and Cell Sorting Shared Resource is partially supported by an NCI Comprehensive Cancer Center Support Grant ( 2-P30- CA016520 ). This work was supported by the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases P30 Center for Molecular Studies in Digestive and Liver Diseases ( P30-DK050306 ), its pilot grant program, and scientific core facilities (Molecular Pathology and Imaging, Molecular Biology, Cell Culture and Mouse). Funding Information: Disclosure of potential conflict of interest: M. Noti has received research support from the Swiss National Science Foundation . B. S. Kim, M. C. Siracusa, and D. Artis have received research support from the National Institutes of Health (NIH) . M. R. Comeau is employed by and is a shareholder of Amgen. J. M. Spergel has received research support from the Department of Defense; is a board member for the American Academy of Allergy, Asthma & Immunology, the American Partnership for Eosinophilic Disorders, and the International Association for Food Protein Enterocolitis; has consultant arrangements with DBV Technologies and Dannone; has received grants from Food Allergy Research and Education, the NIH, and Allergen Research Corporation ; receives payment for lectures from MEI; receives royalties from UpToDate; receives payment for development of educational presentations from MEI and Abbott; and receives stock/stock options from DBV Technologies. The rest of the authors declare that they have no relevant conflicts of interest. ",
year = "2014",
month = may,
doi = "10.1016/j.jaci.2014.01.021",
language = "English (US)",
volume = "133",
pages = "1390--1399.e6",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "5",
}